# Revelation Biosciences, Inc.: Form 8-K, filed Dec 6, 2024

- Company: [Revelation Biosciences, Inc.](/companies/revb.md) (CIK 1810560)
- Form: 8-K
- Filed: 2024-12-06
- Accepted by EDGAR: Dec 6, 2024, 16:03 ET
- Period: 2024-12-03
- Accession: 0000950170-24-134064
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1810560/000095017024134064/revb-20241203.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810560/000095017024134064/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 3.03: Change to security holders’ rights
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810560/000095017024134064/revb-20241203.htm

Filed Dec 6, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-134064. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.